patients manifested normal concanavalin A-generated suppressor cells of pokeweed mitogen-induced PFC responses in allogeneic co-cultures. This was unlike the suppressor cell defect previously described in this system with systemic lupus erythematosus patients. The discrepancy was attributed both to the fact that the TG defect was reversible and to the fact that concanavalin A-generated suppressor cells are not limited to the TG subset. Thus, these studies have demonstrated reversible abnormalities in TG cells in patients with extraglandular Sjogren's syndrome which are not associated with suppressor cell defects. The discrepancy between these findings and the immunoregulatory defects demonstrated in systemic lupus erythematosus may explain the difference in severity of the autoimmune expression in these diseases. INTRODUCTION Sjogren's syndrome (sicca syndrome) is a chronic autoimmune disease characterized by T-and B-lymphocyte infiltration of exocrine glands, particularly the lacrimal and salivary glands, resulting in xerostomia and xerophthalmia (1, 2) . Extraglandular lymphocytic infiltration occurs in one-fourth of patients and usually presents as interstitial pneumonitis, nephritis, myositis, or pseudolymphoma. Rarely, malignant lymphoma occurs, and recently it was shown that sicca syndrome patients are 40 times more prone to develop lymphoma compared with controls (3-7). Sjbgren's syndrome can exist as a primary disorder with disease limited to the exocrine glands or with additional extraglandular disease (primary Sjogren's syndrome), or as a component of another connective tissue disease such as rheumatoid arthritis or systemic lupus erythematosus (secondary Sjogren's syndrome) (1, 8) .
A number of findings suggestive of B-cell hyperreactivitv and/or abnormalities of immunoregulation occur in Sjogren's syndrome including hypergammaglobulinemia, nonorgan-specific autoantibodies such as
The Journal of Cliniical Inivestigation Volume 65 February 1980 519-528 rheumatoid factor, and antibodies to extractable nuclear antigen(s) (1, (7) (8) (9) (10) . In addition, nonrheumatoid factor-circulating IgG immune complexes have been demonstrated in certaini patients with this disease (11) .
The precise etiology of these abnormalities is unknown. Hyperreactivity of B-cell function may be a primary phenomenon or may be directly or indirectly related to alterations in immunoregulatory mononuclear cells such as thymus-derived (T) cell subpopulations (12) . The present study was undertaken to determine if any abnormalities in immunoregulatory T-cell subpopulations as well as B-cell function occur in Sjogren's syndrome. The study was conducted on patients with Sjogren's (either glandular or extraglandular) without other connective tissue diseases. None of the patients were receiving or had received any form of therapy for their disease.
METHODS
Patientt population. 21 patients with Sjogren's syndrome were studied. There were 1 male and 20 females, ranging in age from 34 to 75 yr. The diagnosis was based on the presence of the following findings: xerostomia (decreased parotid flow rate, abnormal parotid scan), keratoconjunctivitis sicca demonstrated on slit-lamp examination, and a focal lymphocyte infiltrate on minor salivary gland biopsy. All patients had Sjogren's syndrome alone (primary Sjogren's syndrome) without other connective tissue diseases (1). 10 ofthe patients had disease limited to exocrine glands, and the remaining 11 had the following extraglandular manifestations: hypergammaglobulinemic purpura, pseudolymphoma, biopsy-proven vasculitis, renal involvement (urine pH higher than 7, serum bicarbonate concentration lower than 19 meq/dl, decreased creatinine clearance, and interstitial nephritis on renal biopsy), and interstitial pneumonitis demonstrable on chest roentgenogram and pulmonary function tests (Table I) . None of the patients studied were receiving any form of therapy, nor had they ever received any form of therapy for their disease.
The normal control group consisted of 11 age-, sex-, and race-matched individuals.
Cell suspensions. Mononuclear cell suspensions were obtained from heparinized venous blood of patients and normal controls by standard Hypaque-Ficoll gradient centrifugation. Cells were counted in a Coulter counter (model Fn, Coulter Electronics Inc., Hialeah, Fla.), and mononuclear cells were examined in cytocentrifuge preparations stained with WrightGiemsa stain. T cells were identified by the presence of a sur- Hypergammaglobulinemic purpura face receptor for sheep erythrocytes (E),' and bone marrowderived (B) cells were identified bv the presence of surface immunoglobulin (slg) deterrnined by a fluoresceinated F(ab)2 goat anti-human Ig reagent as previously described (13) . Fractionation of mononuclear cell suspensions. T cellenriched suspensions were obtained by E-rosetting of lvmphocytes with sheep erythrocytes (SRBC) followed by centrifugation of rosetted cells over Hypaque-Ficoll gradients as previously described in detail (14) . E-rosetted cells (T cellenriched) separated into the pellet, leaving nonrosetted cells (T cell-depleted) at the interface. T cell-enriched suspensions contained greater than 98% T cells, and T cell-depleted suspensions contained less than 1% T cells. Greater than 90% of the cells were recovered after the fractionation procedure.
Identification of T-cell subpopulations. T-cell subpopulations were determined as previously described in detail (15, 16) . Briefly, to identify T cells bearing receptors for the Fc portion of IgG (TG), 0.1 ml of purified T cells at a concentration of 10 X 106 cells/ml was mixed with 0.1 ml of a 2% suspension of bovine E coated with highly purified rabbit antibovine E IgG antibody (7S EA). This mixture was spun into a pellet and incubated at 370 C for 30 min. To identify T cells bearing receptors for the Fc portion of IgM (TM cells), purified T cells were incubated overnight at a concentration of 106 cells/ml in TC 199 media (Grand Island Biological Co., Grand Island, N. Y.) and 20% fetal calf serum. After overnight incubation, the T cells were suspended in TC 199 at 3 x 106 cells/ml, and 0.1 ml was added to 0.1 ml of a 0.5% suspension of bovine E coated with purified rabbit antibovine E IgM (19S EA). The Tcell-19S EA mixture was spun into a pellet and incubated on ice for 45 min.
After viduals. Separate aliquots of T cells were then preincubated for 45 min at 37°C with 1:10 dilution of heat-inactivated sera from normal individuals or from patients with Sjogren's syndrome. Cells were then washed twice and TG determinations were repeated.
For the experiments using serum fractions, the following procedures were carried out: sera from three patients and one normal individual were heat-inactivated at 56°C for 30 min and were fractionated on a Bio-Gel A 1.5 column (1 x 90 cm) as previously described (17) . 1-ml fractions were collected from the column and localization ofthe 19S (IgM) and 7S (IgG) peaks was performed by radial immunodiffusion (Hyland Diagnostics Div., Travenol Laboratories, Inc., Costa Mesa, Calif.). The fractions were then dialyzed against phosphatebuffered saline (pH 7.4), concentrated to the original volume and airfused before use (Airfuse; Beckman Instruments, Inc., Fullerton, Calif.).
In a separate series of experiments the serum fractions from a patient with extraglandular Sjogren's syndrome and a low proportion of TG (2%), serum from a patient with glandular Sjogren's syndrome and a normal proportion of TG (12%), and serum from a normal individual (15% TG) were fractionated by multiple passages over a column of Sepharose 4B with bound staphylococcal protein A (Pharmacia Fine Chemicals, Div. Pharmacia Inc., Piscataway, N. J.) according to previously described methods (18) . Pooled serum fractions either devoid of detectable IgG or enriched in IgG were obtained by this fractionation procedure. Preincubation of T cells with the serum fractions was carried out in the same manner as described above for the unfractionated sera. Blastogenic responses. Lymphocyte blastogenic responses to stimulation with the mitogens phytohemagglutinin (PHA) (concentration range from 0.5 to 10 gg/ml of culture), concanavalin A (Con A) (10-250 ,ug/ml of culture), and pokeweed mitogen (PWM) (1:20 through 1:1,000 dilution of stock solution per milliliter of culture) were determined by the incorporation of tritiated thymidine in microcultures as previously described in detail (13) . Cultures stimulated with PHA and Con A were incubated for 3 d, and cultures stimulated with PWM were incubated for 5 d.
Determination of plaque-forming cell (PFC) responses. Determination of B cells spontaneously producing Ig was made by immediately assaying freshly drawn Hypaque-Ficollseparated mononuclear cells in a hemolysis-in-gel PFC assay as previously described (19) , with the modification that the SRBC targets were haptenated with the trinitrophenyl hapten (20) .
The polyclonally induced PFC responses against SRBC of lymphocytes from Sjogren's syndrome patients and normal subjects after 6-7 d of culture with PWM were also determined as previously described (19) . Briefly, cells were cultured in RPMI-1640 media (Grand Island Biological Co.) containing 0.3% trypticase soy broth, 2 mM L-glutamine, 100 U/ml ofpenicillin, 100 ,ug/ml of streptomycin sulfate, and supplemented with 10% pooled human A serum absorbed twice with SRBC. Cultures were performed in 12 x 75-mm plastic tubes (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) at a density of 2 x 106 cells in 1 ml, on a rocker platform (7 cycles/min) for 6-7 d at 37°C in 5% CO2 in air at 100% humidity. Cultures were stimulated either with PWNI in a wide concentration range (1:20 through 1:10,000 final dilution) or media alone as control (background PFC).
In allogeneic co-cultures of cell suspensions from a Sjogren's syndrome patient and a normal individual, 1 x 106 cells of one suspension were co-cultured with 1 x 106 cells of another suspension to keep the cell density constant at 2 x 106 cells in 1 ml. At the end ofthe culture period (6-7 d), cells were harvested and assayed for direct PFC against SRBC by an ultrathin layer hemolysis-in-gel technique as previously described in detail (19) . Data are expressed as PFC per 106 cells.
Con A-generated suppressor cells. Suppressor cells were activated by incubation with Con A (grade IV, Sigma Chemical Co.) as previously described in detail (21) . Briefly, lymphocytes at a density of 5 x 106 cells/2 ml of RPMI-1640 were incubated in flat-bottomed Linbro plates (Linbro Chemical Co., Hamden, Conn.) either with 10 ug/ml Con A, a dose previously shown to be optimal for generating suppressor cells (21), or with no Con A as a control. At 48 h, cells were harvested, washed three times with 0.2 M a-methyl mannoside (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.), and once with RPMI-1640 media. Control cells were not exposed to Con A on initiation of culture, but were cultured alone for 48 h and washed with a--methyl mannoside in the same manner as the cells that were cultured with Con A. Con A-activated or control cells (unstimulated) from normals or patients were co-cultured with freshly drawn allogeneic normal lymphocytes in the presence of PWM for an additional 6-7 d to determine the effect of Con A-activated suppressor cells on the PWM-induced PFC response against SRBC.
RESULTS
Lytm phocyte subpopulations. The absolute numbers of lymphocytes, total T cells, and B cells in normal individuals and patients with either glandular Sjogren's syndrome or extraglandular Sjogren's syndrome are shown in Fig. 1 . There were no significant differences between normal individuals and patients with glandular Sjogren's syndrome in absolute numbers of lymphocytes, T cells, or B cells. Patients with extraglandular Sjogren's syndrome had slightly lower numbers oftotal lymphocytes and T cells than normal individuals, but these differences were not significant. When relative proportions of T-cell subsets were determined, again there were no significant differences among normals, glandular, and extraglandular Sjogren's syndrome patients (Fig. 2) . However, when proportions of TG cells (by 7S EA-rosetting) were examined in individual patients with glandular and extraglandular Sjogren's syndrome, an obvious difference was noted (Fig. 3) Sjogren's syndrome patients with normal TG-cell proportions, and from extraglandular Sjogren's syndrome patients with low TG-cell proportions is shown in Fig. 4 . Preincubation of T cells with normal sera or sera from patients with glandular Sjogren's syndrome and normal TG-cell levels had very little effect on the detection of IgG Fc receptors on these normal T cells. In contrast, sera from each of six patients tested with extraglandular Sj6gren's syndrome who had low TG cell proportions blocked the expression of the IgG Fc receptor on normal T cells. In additional studies in which normal T cells were incubated with sera at 27°C or 4°C, sera from normals or patients with glandular Sjogren's syndrome and normal proportions ofTG still did not block the expression ofthe IgG Fc receptor on the normal T cells. This suggests that low titer-blocking factors which might bind detectably only at lower temperatures were not present in the sera of normal individuals and patients with normal TGEffect of serum fractions. Sera from normal individuals and patients with extraglandular Sj6gren's syndrome whose whole serum had blocked the expression of the IgG Fc receptor on normal T cells were fractionated over Bio-gel A 1.5 columns. The Fc receptorblocking activity was found in the fractions containing IgG and in fractions containing IgM. In a separate series of experiments in which various sera were fractionated into IgG-containing and IgGdepleted fractions by passage over columns of staphylococcal protein A bound to Sepharose 4B, only the IgG-containing fraction ofthe patient with extraglandular Sj6gren's syndrome and low TG proportion blocked the expression of the IgG Fc receptor on normal T cells (Table III) Normal T cells were preincubated with either media, whole serum, or serum fractions before determination of the proportion of TG (Methods). extraglandular Sjdgren's syndrome were markedly decreased below normal (P < 0.001).
The low PFC responses of the extraglandular Sjogren's syndrome patients were not due to the exces-FIGURE 6 Peak blastogenic responses of normals and Sjogren's svndrome patients to mitogenic stimulation. There were no significant differences (P > 0.2) among the three groups in blastogenic responises to PHA, Con A, or PWM. sive activity of suppressor cells since co-culture of normal lymphocytes with low responder Sjogren's syndrome lymphocytes, a procedure which detects active suppressor cells (22) , did not decrease the expected PFC responses of the normal lymphocytes. Con A-generated suppressor cells. Lymphocytes from patients with Sj6gren's syndrome (either glandular or extraglandular) generated Con A-induced suppressor cells normally. In particular, mononuclear cells from patients, when cultured for 48 h with Con A, subsequently suppressed the anti-SRBC PFC responses when added to PWM-stimulated allogeneic cocultures. The suppression was no different from that (23, 24) as well as T-cell subsets determined by a number of other methodologies (25) (26) (27) (28) (29) . This is of particular relevance in light of the fact that in several in vitro systems, SLE has been demonstrated to manifest a deficiency of suppressor cell function (23, (30) (31) (32) (33) (34) (35) . Although the actual suppressor cell in most of these systems has not been conclusively identified, at least in some systems of in vitro B-cell function, the TG cell has been demonstrated to be the suppressor cell (16) . With regard to the relationship between deficiency ofTG cells and lack of suppressor cell function, it should be pointed out that patients with SLE in addition to the deficiency of TG cells (23, 24) also manifest a defective ability to generate, after triggering with Con A, suppressor cells of PWMinduced PFC responses (23) . In the present study, (43) (44) (45) . We have previously hypothesized that the preactivation of circulating IgM-producing B cells in SLE was likely due to an in vivo polyclonal triggering (23) . This was accompanied by a decrease in ability to be triggered in vitro by a de novo polyclonal stimiiulus such as PWMI and hence a decreased PWMN-induced anti-SRBC PFC response (23) as was demonstrated in the present study with patients with the more severe extraglandular (lisease. This same theory was hypothesized by others for the simultaneous in vivo hyperreactivity of B cells and decreased ability of B cells to be polyclonally triggered in vitro as demonstrated in the NZB/NZW mouse model of SLE (46) (47) (48) .
Since Sjogren's syndrome is a disease of hyperreactivity of B cells, the in vivo preactivation theory is still a likely explanation. Cells that have been preactivated to the point of appearing as spontaneous IgM-producing PFC might not have been found in the circulation in Sjogren's syndromie because they had already been compartmentalized in other lymphoid organs.
Previous studlies have demonstrated a T lymphocytopenia in Sjdgren's syndrome (49, 50) , whereas in this study absolute numbers of T-cell subpopulations in patients with Sjogren's syndrome were found to be within normal limits. It should be pointed out that these patients differ from the Sj6grein's syndrome patients in these other studies inasmuch as our patients had Sjogren's syndrome alone without any other concomitant connective tissue diseases such as rheumatoid arthritis or SLE. Also, and perhaps most importantly, none of the patients in the present study were receiving any form of therapy nor had they ever received any form of therapy for their Sjogren's syndrome. In this regard, the profound and selective effects of agents such as corticosteroids on T cells and T-cell subpopulations has been previously described (51, 52) .
Thus the present study has demonstrated that certain patients with Sj6gren's syndrome, particularly of the extraglanidular type without coexisting additional connective tissuie diseases, have a deficiency of expression of the Fc receptor for IgG on a population of'their T cells (T(; cells). The defective expression is caused by the reversible blockinig by a serum factor. This reversibility of effect mnay explain the lack of detectable abnormalities of modulation of immunoregulatory lymphocyte subpopulations in Sjogren's syndrome as compared with SLE in which irreversible deficiencies of Fc receptor-bearing T cells are accompanied by profound immunoregulatory abnormalities.
